Abbott Laboratories Exceeds Revenue and Earnings Expectations, Raises FY26 Profit Guidance
Abbott Laboratories (ABT) reported Q2 non-GAAP earnings per share of $1.31, surpassing estimates by $0.03, with revenue reaching $12.59 billion—up 13% year-over-year and beating expectations by $70 million. The company raised its full-year adjusted diluted EPS guidance for FY26 while reaffirming sales growth projections of 6.5% to 7.5%.
Tickers: $ABT